AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS - 2025 Issue 3; Ask the Editor
Pancytopenia due to Chimeric Antigen Receptor (CAR) T-Cell Therapy
A patient with relapsed IgA lambda multiple myeloma is diagnosed with pancytopenia due to chimeric antigen receptor (CAR) T-cell therapy. What is the correct code assignment for pancytopenia due to CAR T-cell therapy? Would it be considered a complication or an adverse effect? ...
Subscribe or sign in to view the full article.
Article Overview
This short coding article explains how to approach diagnosis coding when pancytopenia occurs in the setting of CAR T-cell therapy. It is intended for coders and clinical documentation teams working with ICD-10-CM and immune effector cellular therapy-related diagnoses. The article covers the relevant classification context and identifies the diagnosis codes involved in the scenario.
Why This Topic Matters
CAR T-cell therapy is increasingly seen in oncology and hematology, and accurate diagnosis classification affects code selection and documentation review. This article helps readers understand the coding category involved and the related pancytopenia diagnosis in an ICD-10-CM context.
What You Will Learn
- How pancytopenia related to CAR T-cell therapy is discussed in ICD-10-CM terms.
- Which diagnosis coding categories are implicated in the scenario.
- How the article frames the classification question for therapy-related blood count abnormalities.
- How immune effector cellular therapy is referenced in relation to coding.
Who Should Read This
- Medical coders
- Coding auditors
- Clinical documentation improvement specialists
- Hematology/oncology billing staff
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com